SpringWorks Therapeutics (SWTX) Soars 9.0%: Is Further Upside Left in the Stock?

SpringWorks Therapeutics (SWTX) shares rallied 9% in the last trading session to close at $44.93. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 11.3% loss over the past four weeks.The sudden price rise can be attributed to growing investors’ optimism related to the company’s progress with its lead marketed product, Ogsiveo (nirogacestat), which is approved for treating Desmoid tumors. The drug has witnessed ...